Zumiez (ZUMZ) Q1 2026 earnings review
A Tale of Two Continents: Europe Rebounds as North America Stalls
Zumiez delivered a mixed Q1 report that masks a significant underlying geographic shift. While total Q1 comparable sales grew 4.0% (hitting the top end of guidance) and gross margins expanded a healthy 170 basis points, the intra-quarter momentum is reversing. Management's long-struggling European turnaround is finally gaining traction, but the core North American business—the primary growth engine over the last two years—suddenly turned negative in May. With Q2 revenue guidance implying a slight year-over-year contraction, the margin recovery story is now racing against a softening domestic consumer.
🐂 Bull Case
The full-price selling strategy is working. Gross margin improved 170 basis points to 31.7%, driving operating loss down by $4.7M year-over-year despite ongoing macro pressures.
After multiple quarters of painful mid-to-high single-digit declines, the international segment (primarily Europe) violently reversed trend, posting a +7.2% comp in May. If sustained, this eliminates a massive historical drag on consolidated earnings.
🐻 Bear Case
The U.S. consumer is showing signs of exhaustion. After eight consecutive quarters of growth, North American comps went negative (-1.5%) in May, contradicting management's claim of 'ongoing strength' in the region.
The Q2 revenue guidance midpoint of $212.5M implies a ~0.8% YoY decline. Furthermore, guided Q2 EPS (-$0.23 to -$0.08) represents a deterioration from the prior year's -$0.06.
⚖️ Verdict: ⚪
Neutral. The operational discipline (margin expansion, inventory control) is commendable and Europe's recovery is a major positive. However, a specialty apparel retailer cannot outrun a decelerating North American consumer. The Q2 guidance reflects this sobering reality.
Key Themes
Full-Price Strategy Drives Margin Expansion
Despite a tough macro backdrop, Zumiez is extracting better profitability from its sales base. Gross profit grew 10.9% to $61.3M, vastly outpacing the 4.9% top-line growth. The gross margin rate expanded 170 bps to 31.7%. Concurrently, SG&A was leveraged down to 39.6% from 40.8%. This accelerating operational efficiency proves the core merchandising strategy (including ~30% private label penetration) can defend margins even when volume slows.
The May Macro Wall
A concerning trend break occurred in May. Total comps for the four weeks ending May 30 turned negative (-0.1%), dragging down the entire Q2 outlook. Management explicitly blamed 'increasing pressure on consumers' in North America. This is a reversing trend from the robust +7.5% run-rate the company experienced in early February and suggests that the low-end consumer discretionary wallet is tightening heading into the critical back-to-school season.
The EPS Optical Illusion
Zumiez presents an interesting quirk in capital structure math this quarter. Net loss actually improved to -$13.3M (from -$14.3M a year ago), and operating loss improved by nearly $4.7M. However, diluted loss per share worsened from -$0.79 to -$0.82. This optical deceleration is entirely due to the company aggressively repurchasing shares (weighted average shares down ~10.5% YoY to 16.2M). Investors should focus on operating income improvements rather than the headline EPS miss.
Store Fleet Rationalization Accelerates
The physical footprint continues to shrink. Management confirmed plans to close roughly 26 stores in FY26 (20 in NA, 6 internationally) against only 5 openings. While this prunes underperforming assets and aids occupancy leverage, it mathematically caps top-line revenue growth and places a heavier burden on digital channels and comparable store sales to drive absolute dollar growth.
Other KPIs
A remarkably strong cash generation quarter for a retailer in a seasonal lull. This operating cash flow, combined with a $3.0M release in restricted cash, bolstered the balance sheet to $124.2M in cash and marketable securities, providing ample liquidity for ongoing share repurchases ($6.2M spent in Q1).
Stable. Inventory is up a modest 2.2% YoY (from $149.9M). Given the 4.9% sales growth in Q1, inventory is growing slower than sales, indicating a clean channel and supporting management's successful full-price selling narrative without the need for aggressive markdowns.
Guidance
Decelerating. The midpoint of $212.5M implies a 0.8% decline compared to 25Q2 sales of $214.3M. This confirms the negative sales trend observed in May is expected to persist through the summer months.
Decelerating. At the midpoint (-$0.155), this is notably worse than the -$0.06 reported in 25Q2. Even factoring in the reduced share count, this implies a year-over-year contraction in net income for the upcoming quarter, likely driven by the lack of sales leverage on fixed costs.
Key Questions
North American Consumer Health
North American comps flipped from +5.5% in Q4 to -1.5% in May. Is this deceleration broad-based across all income demographics, or concentrated in specific product categories like footwear which has historically struggled?
European Turnaround Sustainability
The international comp of +7.2% in May is a massive swing. How much of this is driven by sustainable full-price selling traction versus simply lapping extremely weak, highly promotional comparisons from the prior year?
Private Label Ceiling
With private label historically reaching around 30% of sales, has the company hit a natural ceiling for this higher-margin category, or is there runway to expand this penetration further to offset the softening top-line?